Fletcher, Mary Ann, Zeng, Xiao Rong, Barnes, Zachary et al. · Journal of translational medicine · 2009 · DOI
Researchers tested blood samples from women with ME/CFS and compared them to healthy women to look for immune system differences. They measured 16 different immune substances called cytokines and found that 10 of them were abnormal in ME/CFS patients—some were higher and some were lower than in healthy controls. While these differences suggest immune activation in ME/CFS, the pattern wasn't specific enough to use as a diagnostic test on its own.
This study addresses the critical need for objective biomarkers in ME/CFS diagnosis and prognosis by systematically measuring a large cytokine panel with modern multiplex technology. The identification of specific cytokine abnormalities, particularly IL-5 and LTα, provides potential targets for therapeutic intervention and demonstrates feasibility of immune profiling as a diagnostic approach.
This study does not establish whether cytokine abnormalities cause ME/CFS symptoms, are merely associated with the disease, or represent secondary effects of prolonged immune activation and inflammation. The study also does not demonstrate that any single cytokine is specific enough for clinical diagnosis, nor does it clarify whether cytokine patterns differ across ME/CFS subtypes or disease stages.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.